VALSARTAN RECALL LAWSUITS

In July of 2018, the U.S. Federal Drug Administration (FDA) began issuing safety warnings and recalls of certain versions of drug products containing the Active Pharmaceutical Ingredient (API) Valsartan. The recalled products contain an impurity, NDMA and/or NDEA, which pose an increased risk of cancer or other serious injury.

Recalled Valsartan lawsuits are being reviewed by the Law Offices of Kenneth W. DeJean for:

  • Kidney Injuries
  • Liver Injuries
  • Breast Cancer
  • Kidney Cancer
  • Liver Cancer
  • Intestinal Cancer
  • Colon Cancer
  • Bladder Cancer
  • Pancreatic Cancer
  • Stomach Cancer

The pharmaceutical drug attorneys at the Law Offices of Kenneth W. DeJean are reviewing potential Valsartan lawsuits. We invite you to call our office today for a complimentary Valsartan lawsuit evaluation. Begin the process of evaluating your Valsartan lawsuit by completing our case evaluation form here or call our office at (337) 235-5294 or (800) 284-3962.

VALSARTAN

Valsartan and valsartan-containing drug products are medications commonly prescribed by doctors to treat heart failure and high blood pressure (hypertension).1 The FDA has recalled certain versions of Valsartan and Valsartan-containing medications due to the presence of an impurity, NDMA and/or NDEA.2

NDMA AND NDEA

The U.S. Environmental Protection Agency (EPA) considers NDMA and NDEA probable human carcinogens - a chemical that can increase the risk of cancer in humans.3

According to the EPA, NDMA was formerly used in the production of rocket fuel and is currently only used for research purposes. The EPA has classified NDMA as a B2 (probable human) carcinogen based on the induction of tumors at multiple sites in different animal species exposed to NDMA by various routes.4 The U.S. Department of Health and Human Services states that NDMA is reasonably anticipated to be a human carcinogen. 5

The EPA has found that exposure to high levels of NDMA may cause liver, kidney and lung damage as well as cancers of these organs.

The presence of the potentially cancer-causing NDMA and/or NDEA is believed to be related to changes in the way the active substance was manufactured. Some levels of the impurity may have been in the valsartan-containing products for as long as four years.6

LIST OF VALSARTAN PRODUCTS UNDER FDA RECALL

Click here to view a full list of recalled medications containing Valsartan (updated by FDA, as of November 27, 2018). The FDA has not recalled all medications containing Valsartan. A list of Valsartan-containing drugs that are not affected by the recall can be found here.

As of November 30, 2018, the FDA investigation of valsartan-containing medications is ongoing. For the latest information from the FDA, visit their website here.

ARE YOU CURRENTLY TAKING VALSARTAN?

The FDA has provided the following information for patients currently taking Valsartan medications that are under recall:

  • Continue taking your current medicine until your doctor or pharmacist gives you a replacement or a different treatment option. 7
  • Not all valsartan-containing medications are affected and being recalled. 8
  • If you are taking any medication containing valsartan, compare the information on your prescription bottle with the information in this list (Company, National Drug Code and Lot number) to determine if your current medicine has been recalled. If you are not certain, contact your pharmacist. 9
  • If you have medicine included in the recall, contact your pharmacist. The pharmacist may be able to provide you with Valsartan made by another company. If not, contact your doctor immediately to discuss other treatment options.10

The FDA reminds consumers to continue taking your current medications until your doctor or pharmacist gives you a replacement or a different treatment option. Untreated hypertension (high blood pressure) leads to an increase in the risk of heart attacks and stroke. Untreated heart failure increases the risk of hospitalization and death.11

CONTACT A DANGEROUS DRUG ATTORNEY AT THE LAW OFFICES OF KENNETH W. DEJEAN TODAY

If you or a loved one has been diagnosed with cancer or developed kidney or liver damage after using recalled Valsartan, contact a dangerous drug attorney in Lafayette, Louisiana at The Law Offices of Kenneth W. DeJean today. Our experienced pharmaceutical drug lawyers can help you determine if you may have a Recalled Valsartan lawsuit.

CONTACT OUR OFFICE TODAY FOR A COMPLIMENTARY VALSARTAN LAWSUIT EVALUATION OR FILL OUT OUR CASE EVALUATION FORM HERE.

The Law Offices of Kenneth W. DeJean
Phone: (337) 235-5294
Toll Free: (800) 284-3962
www.kwdejean.com